In Bangalore, India, as of January 22, 2026, the global radiopharmaceuticals market was reported to have reached a revenue of USD 6761 million in 2022. Projections indicate that this market is expected to experience significant growth, with an anticipated readjusted size of USD 11660 million by 2029. The compound annual growth rate (CAGR) during the forecast period from 2023 to 2029 is estimated to be 8.0%.